Medicare Enrolled
Dr. Michael Moffett, M.D.
Hematology & Oncology · Clovis, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Moffett from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Moffett?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Moffett
Dr. Michael Moffett is a hematology & oncology specialist in Clovis, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Moffett performed 5,263 Medicare services across 2,354 unique beneficiaries.
Between the years covered by Open Payments, Dr. Moffett received a total of $13,618 from 59 pharmaceutical and/or device companies across 411 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Moffett is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 32% volume in CA
$13,618 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,263
Medicare services
Top 32% in CA for hematology & oncology
2,354
Unique beneficiaries
$80
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~277 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,198 | $93 | $316 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,768 | $61 | $223 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
301 | $137 | $438 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
208 | $97 | $293 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
176 | $63 | $196 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
139 | $1 | $5 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
137 | $11 | $48 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
120 | $123 | $428 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
79 | $40 | $118 |
| New patient office visit, complex (60-74 min) | 73 | $159 | $554 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
44 | $85 | $288 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
20 | $36 | $143 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$13,618
Total received (2018-2024)
Avg $1,945/year across 7 years
Top 27% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
59
Companies
411
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,355 (46.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,286 (31.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,977 (21.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$626
2023
$353
2022
$156
2021
$615
2020
$1,028
2019
$6,524
2018
$4,316
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Exelixis Inc.
$309
ABBVIE INC.
$201
AstraZeneca Pharmaceuticals LP
$60
SOBI, INC
$38
Daiichi Sankyo Inc.
$18
Top 3 companies account for 91.1% of 2024 payments
All-time payments by company (2018-2024) ›
TESARO, Inc.
$4,299
Seattle Genetics, Inc.
$2,834
Exelixis Inc.
$920
E.R. Squibb & Sons, L.L.C.
$688
Secura Bio, Inc.
$511
PFIZER INC.
$454
Novartis Pharmaceuticals Corporation
$320
Merck Sharp & Dohme Corporation
$298
Daiichi Sankyo Inc.
$234
AstraZeneca Pharmaceuticals LP
$233
ABBVIE INC.
$223
Pharmacyclics LLC, An AbbVie Company
$210
Amgen Inc.
$198
Octapharma USA, Inc.
$174
Janssen Biotech, Inc.
$170
Genentech USA, Inc.
$137
Alexion Pharmaceuticals, Inc.
$127
SECURA BIO, INC.
$104
Astellas Pharma US Inc
$91
Takeda Pharmaceuticals U.S.A., Inc.
$89
Lilly USA, LLC
$89
GENZYME CORPORATION
$89
AbbVie, Inc.
$74
MEDIVATION FIELD SOLUTIONS LLC
$65
Cardinal Health 108, LLC
$65
Seagen Inc.
$57
Gilead Sciences, Inc.
$45
EISAI INC.
$45
Bayer HealthCare Pharmaceuticals Inc.
$44
Ipsen Biopharmaceuticals, Inc
$44
Lexicon Pharmaceuticals, Inc.
$40
Stemline Therapeutics Inc.
$38
SOBI, INC
$38
Incyte Corporation
$37
Teva Pharmaceuticals USA, Inc.
$36
Eisai Inc.
$33
GlaxoSmithKline, LLC.
$32
Regeneron Healthcare Solutions, Inc.
$31
Taiho Oncology, Inc.
$29
TerSera Therapeutics LLC
$28
Karyopharm Therapeutics Inc.
$24
Foundation Medicine, Inc.
$24
Rigel Pharmaceuticals, Inc.
$23
PharmaEssentia USA Corporation
$22
Janssen Pharmaceuticals, Inc
$22
AbbVie Inc.
$21
R-Pharm US LLC
$20
Otsuka America Pharmaceutical, Inc.
$20
Dendreon Pharmaceuticals LLC
$18
Puma Biotechnology, Inc.
$18
EMD Serono, Inc.
$18
BeiGene USA, Inc.
$15
Shire North American Group Inc
$15
Celgene Corporation
$15
Tactile Systems Technology Inc
$14
Advanced Accelerator Applications
$14
ARRAY BIOPHARMA INC
$13
Dova Pharmaceuticals
$13
AMAG Pharmaceuticals, Inc.
$13
Top 3 companies account for 59.1% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · Aliqopa · BENDEKA · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · CABOMETYX · CALQUENCE · CHANTIX · COPIKTRA · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELZONRIS · ERBITUX · ERLEADA · Enhertu · Erivedge · Erleada · FARYDAK · FASLODEX · FERAHEME · FIBRYGA · FLEXITOUCH · FOUNDATIONONE LIQUID CDX · IBRANCE · ICLUSIG · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · INQOVI · Imbruvica · Ixempra · JADENU · JAKAFI · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lupron · Lupron Depot · MEKINIST · MVASI · NERLYNX · Neulasta · Nplate · Nubeqa · OCTAPLAS · OPDIVO · PADCEV · PROMACTA · PROVENGE · Perjeta · REBLOZYL · Revlimid · SANDOSTATIN LAR · SARCLISA · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUTENT · TAFINLAR · TECENTRIQ · Tavalisse · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VONVENDI · VOTRIENT · Venclexta · WILATE · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XALKORI · XARELTO · XGEVA · XPOVIO · XTANDI · Xermelo · YERVOY · ZEJULA · ZEPOSIA · ZOLADEX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (47%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
28
Per 100K population
2.8
County median income
$71,434
Nearest hospital
CLOVIS COMMUNITY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Moffett is a clinical cardiology specialist, with moderate Medicare volume, with mixed engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Moffett experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Moffett performed 2,198 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Moffett receive payments from pharmaceutical companies?
Yes. Dr. Moffett received a total of $13,618 from 59 companies across 411 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Moffett's costs compare to other hematology & oncology specialists in Clovis?
Dr. Moffett's average Medicare payment per service is $80. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Moffett) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Clovis
Browse hematology & oncology specialists in Clovis ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
TESARO, Inc. Payments to Doctors
See all physicians who received payments from TESARO, Inc.
By company
Seattle Genetics, Inc. Payments to Doctors
See all physicians who received payments from Seattle Genetics, Inc.
By company
Exelixis Inc. Payments to Doctors
See all physicians who received payments from Exelixis Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology